Clinical Trial Detail

NCT ID NCT03708224
Title Phase II Study of Perioperative Immunotherapy in Patients With Advanced Non-Virally Associated Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

oropharynx cancer

nasopharynx carcinoma

head and neck squamous cell carcinoma

Therapies

Atezolizumab + Emactuzumab

Atezolizumab

Age Groups: adult senior

No variant requirements are available.